149 related articles for article (PubMed ID: 21186975)
1. Adolescent with treatment-refractory schizophrenia and clozapine-induced cardiomyopathy managed with high-dose olanzapine.
Bobb VT; Jarskog LF; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):539-43. PubMed ID: 21186975
[No Abstract] [Full Text] [Related]
2. Masked clozapine-induced cardiomyopathy.
Pastor CA; Mehta M
J Am Board Fam Med; 2008; 21(1):70-4. PubMed ID: 18178706
[TBL] [Abstract][Full Text] [Related]
3. Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy.
Floreani J; Bastiampillai T
Aust N Z J Psychiatry; 2008 Aug; 42(8):747-8. PubMed ID: 18642408
[No Abstract] [Full Text] [Related]
4. Schizophrenia past clozapine: what works?
Mustafa FA
J Clin Psychopharmacol; 2013 Feb; 33(1):63-8. PubMed ID: 23277242
[TBL] [Abstract][Full Text] [Related]
5. Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; DeThomas C; Cullen K; Regan J; Kane JM
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):307-16. PubMed ID: 18759640
[TBL] [Abstract][Full Text] [Related]
6. High-dose olanzapine for treatment-resistant schizophrenia.
Roth BL
J Clin Psychiatry; 2008 Feb; 69(2):176-7. PubMed ID: 18363451
[No Abstract] [Full Text] [Related]
7. Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.
Kumra S; Kranzler H; Gerbino-Rosen G; Kester HM; De Thomas C; Kafantaris V; Correll CU; Kane JM
Biol Psychiatry; 2008 Mar; 63(5):524-9. PubMed ID: 17651705
[TBL] [Abstract][Full Text] [Related]
8. Reversible delayed onset olanzapine-associated leukopenia and neutropenia in a clozapine-naive patient on concomitant depot antipsychotic.
Thinn SS; Liew E; May AL; Chua HC; Sim K
J Clin Psychopharmacol; 2007 Aug; 27(4):394-5. PubMed ID: 17632225
[No Abstract] [Full Text] [Related]
9. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
[TBL] [Abstract][Full Text] [Related]
10. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.
Szota A; Ogłodek E; Araszkiewicz A
Pharmacol Rep; 2013; 65(2):279-87. PubMed ID: 23744413
[TBL] [Abstract][Full Text] [Related]
11. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
[No Abstract] [Full Text] [Related]
12. Prolongation of clozapine-induced leukopenia with olanzapine treatment.
Sayin A; Cosar B
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):958-9. PubMed ID: 16631295
[TBL] [Abstract][Full Text] [Related]
13. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.
Naber D; Riedel M; Klimke A; Vorbach EU; Lambert M; Kühn KU; Bender S; Bandelow B; Lemmer W; Moritz S; Dittmann RW
Acta Psychiatr Scand; 2005 Feb; 111(2):106-15. PubMed ID: 15667429
[TBL] [Abstract][Full Text] [Related]
14. The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study.
Conley RR; Kelly DL; Beason-Held LL; Holcomb HH; Richardson CM
J Psychopharmacol; 2004 Sep; 18(3):429-31. PubMed ID: 15358989
[TBL] [Abstract][Full Text] [Related]
15. Treatment-refractory schizophrenia in children and adolescents: an update on clozapine and other pharmacologic interventions.
Kranzler HN; Kester HM; Gerbino-Rosen G; Henderson IN; Youngerman J; Beauzile G; Ditkowsky K; Kumra S
Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):135-59. PubMed ID: 16321728
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
Bitter I; Dossenbach MR; Brook S; Feldman PD; Metcalfe S; Gagiano CA; Füredi J; Bartko G; Janka Z; Banki CM; Kovacs G; Breier A;
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):173-80. PubMed ID: 14687871
[TBL] [Abstract][Full Text] [Related]
17. Experiences with clozapine and olanzapine.
Chatterton R
Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741
[No Abstract] [Full Text] [Related]
18. Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.
Kluge M; Schuld A; Himmerich H; Dalal M; Schacht A; Wehmeier PM; Hinze-Selch D; Kraus T; Dittmann RW; Pollmächer T
J Clin Psychopharmacol; 2007 Dec; 27(6):662-6. PubMed ID: 18004133
[TBL] [Abstract][Full Text] [Related]
19. The choice of antipsychotic drugs for schizophrenia.
Freedman R
N Engl J Med; 2005 Sep; 353(12):1286-8. PubMed ID: 16172204
[No Abstract] [Full Text] [Related]
20. The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study.
Conley RR; Kelly DL; Richardson CM; Tamminga CA; Carpenter WT
J Clin Psychopharmacol; 2003 Dec; 23(6):668-71. PubMed ID: 14624201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
